Sona Nanotech preclinical study shows tumor regression in colorectal cancer model

Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) has announced the publication of a preclinical study examining the efficacy of its Targeted Hyperthermia Therapy (THT) in combination with immunotherapy for ...

Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is excited to announce publication of a preclinical ...
CNET

Nanotech's call to arms

Ask him to predict what sorts of radical technologies might emanate from the newly founded Institute for Soldier Nanotechnologies, and Ned Thomas regales a listener with tales about sleeves that can ...